Here we present a landscape of PD-L1/L2 and PD-1 expression in endometrial tumor tissues resolved into tumor cells and cells of the TME, including lymphocytes, macrophages, tumor-associated blood vessels, and CAFs in the light of pathological parameters, including MMR status. The gene discussed is PDCD1; the disease is endometrium neoplasm.